Journal
AAPS JOURNAL
Volume 8, Issue 4, Pages E693-E708Publisher
SPRINGER
DOI: 10.1208/aapsj080479
Keywords
2-arachidonoylglycerol; anandamide; CB1; fatty acid amide hydrolase; monoacylglycerol lipase; peri-aqueductal gray; rostral ventromedial medulla
Categories
Funding
- NATIONAL INSTITUTE ON DRUG ABUSE [R03DA014265, R01DA014022] Funding Source: NIH RePORTER
- NIDA NIH HHS [DA14022, DA14265] Funding Source: Medline
Ask authors/readers for more resources
Cannabinoids are antinociceptive in animal models of acute, tissue injury-, and nerve injury-induced nociception. This review examines the biology of endogenous cannabinoids (endocannabinoids) and behavioral, neurophysiological, and neuroanatomical evidence supporting the notion that cannabinoids play a role in pain modulation. Behavioral pharmacological approaches, in conjunction with the identification and quantification of endocannabinoids through the use of liquid and gas chromatography mass spectrometry, have provided insight into the functional roles of endocannabinoids in pain modulation. Here we examine the distribution of cannabinoid receptors and endocannabinoid-hydrolyzing enzymes within pain modulatory circuits together with behavioral, neurochemical, and neurophysiological studies that suggest a role for endocannabinoid signaling in pain modulation. This review will provide a comprehensive evaluation of the roles of the endocannabinoids 2-arachidonoyl-glycerol and anandamide in stress-induced analgesia. These findings provide a functional framework with which to understand the roles of endocannabinoids in nociceptive processing at the supraspinal level.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available